Guggenheim Capital’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-123,949
| Closed | -$1.85M | – | 1919 |
|
|
2023
Q4 | $1.85M | Buy |
123,949
+106,452
| +608% | +$1.59M | 0.01% | 872 |
|
|
2023
Q3 | $283K | Sell |
17,497
-371
| -2% | -$5.99K | ﹤0.01% | 1643 |
|
|
2023
Q2 | $742K | Sell |
17,868
-332
| -2% | -$13.8K | 0.01% | 1299 |
|
|
2023
Q1 | $1.09M | Sell |
18,200
-252
| -1% | -$15.2K | 0.01% | 1133 |
|
|
2022
Q4 | $1.35M | Sell |
18,452
-1,723
| -9% | -$126K | 0.01% | 1021 |
|
|
2022
Q3 | $1.53M | Buy |
20,175
+3,132
| +18% | +$238K | 0.01% | 948 |
|
|
2022
Q2 | $1.18M | Buy |
17,043
+2,629
| +18% | +$183K | 0.01% | 1150 |
|
|
2022
Q1 | $1.19M | Buy |
+14,414
| New | +$1.19M | 0.01% | 1264 |
|
|
2021
Q4 | – | Sell |
-27,658
| Closed | -$3.21M | – | 2186 |
|
|
2021
Q3 | $3.21M | Buy |
27,658
+11,781
| +74% | +$1.37M | 0.02% | 834 |
|
|
2021
Q2 | $3.52M | Sell |
15,877
-8,670
| -35% | -$1.92M | 0.02% | 809 |
|
|
2021
Q1 | $3.25M | Buy |
24,547
+2,310
| +10% | +$305K | 0.02% | 803 |
|
|
2020
Q4 | $3.85M | Sell |
22,237
-2,185
| -9% | -$378K | 0.02% | 700 |
|
|
2020
Q3 | $2.72M | Sell |
24,422
-42,079
| -63% | -$4.68M | 0.02% | 762 |
|
|
2020
Q2 | $3.94M | Buy |
+66,501
| New | +$3.94M | 0.03% | 611 |
|
|
2020
Q1 | – | Sell |
-4,592
| Closed | -$387K | – | 1951 |
|
|
2019
Q4 | $387K | Buy |
+4,592
| New | +$387K | ﹤0.01% | 1702 |
|
|
2018
Q4 | – | Sell |
-4,454
| Closed | -$233K | – | 2306 |
|
|
2018
Q3 | $233K | Buy |
+4,454
| New | +$233K | ﹤0.01% | 2292 |
|